학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 358건 | 목록 1~20
Academic Journal
Hontecillas-Prieto L; Clinical Biochemistry Service, Virgen Macarena University Hospital, University of Seville, Seville, Spain.; Department of Medical Biochemistry and Molecular Biology and Immunology, Medical School, Virgen Macarena University Hospital, University of Seville, Seville, Spain.; Clinical Oncology Service, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain.; García-Domínguez DJ; Department of Medical Biochemistry and Molecular Biology and Immunology, Medical School, Virgen Macarena University Hospital, University of Seville, Seville, Spain.; Institute of Biomedicine of Seville, Virgen Macarena University Hospital, CSIC, University of Seville, Seville, Spain.; Jiménez-Cortegana C; Department of Medical Biochemistry and Molecular Biology and Immunology, Medical School, Virgen Macarena University Hospital, University of Seville, Seville, Spain.; Nogales-Fernández E; Clinical Oncology Service, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain.; Department of Medicine, University of Seville, Seville, Spain.; Palazón-Carrión N; Clinical Oncology Service, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain.; Department of Medicine, University of Seville, Seville, Spain.; García-Sancho AM; Department of Hematology, Hospital Universitario de Salamanca, IBSAL, CIBERONC, University of Salamanca, Salamanca, Spain.; Ríos-Herranz E; Department of Hematology, Hospital Universitario de Valme, Seville, Spain.; Gumà-Padrò J; Department of Clinical Oncology, Hospital Universitari Sant Joan de Reus URV, IISPV, Reus, Spain.; Provencio-Pulla M; Department of Medical Oncology, Facultad de Medicina, Hospital Universitario Puerta de Hierro-Majadahonda, Universidad Autónoma de Madrid, IDIPHISA, Madrid, Spain.; Rueda-Domínguez A; Department of Hematology/Clinical Oncology, Hospital Costa del Sol, Marbella, Spain.; de la Cruz-Merino L; Clinical Oncology Service, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain. luis.cruz.sspa@juntadeandalucia.es.; Institute of Biomedicine of Seville, Virgen Macarena University Hospital, CSIC, University of Seville, Seville, Spain. luis.cruz.sspa@juntadeandalucia.es.; Department of Medicine, University of Seville, Seville, Spain. luis.cruz.sspa@juntadeandalucia.es.; Sánchez-Margalet V; Clinical Biochemistry Service, Virgen Macarena University Hospital, University of Seville, Seville, Spain. margalet@us.es.; Department of Medical Biochemistry and Molecular Biology and Immunology, Medical School, Virgen Macarena University Hospital, University of Seville, Seville, Spain. margalet@us.es.; Institute of Biomedicine of Seville, Virgen Macarena University Hospital, CSIC, University of Seville, Seville, Spain. margalet@us.es.
Publisher: BioMed Central Country of Publication: England NLM ID: 101607582 Publication Model: Electronic Cited Medium: Print ISSN: 2049-3002 (Print) Linking ISSN: 20493002 NLM ISO Abbreviation: Cancer Metab Subsets: PubMed not MEDLINE
Academic Journal
Hontecillas-Prieto L; Clinical Biochemistry Service, Virgen Macarena University Hospital, University of Seville, Seville, Spain.; Department of Medical Biochemistry and Molecular Biology and Immunology, Medical School, Virgen Macarena University Hospital, University of Seville, Seville, Spain.; Institute of Biomedicine of Seville, Virgen Macarena University Hospital, CSIC, University of Seville, Seville, Spain.; Clinical Oncology Service, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain.; García-Domínguez DJ; Department of Medical Biochemistry and Molecular Biology and Immunology, Medical School, Virgen Macarena University Hospital, University of Seville, Seville, Spain.; Institute of Biomedicine of Seville, Virgen Macarena University Hospital, CSIC, University of Seville, Seville, Spain.; Palazón-Carrión N; Clinical Oncology Service, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain.; Department of Medicine, University of Seville, Seville, Spain.; Martín García-Sancho A; Department of Hematology, Hospital Universitario de Salamanca, IBSAL, CIBERONC, University of Salamanca, Salamanca, Spain.; Nogales-Fernández E; Clinical Oncology Service, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain.; Department of Medicine, University of Seville, Seville, Spain.; Jiménez-Cortegana C; Department of Medical Biochemistry and Molecular Biology and Immunology, Medical School, Virgen Macarena University Hospital, University of Seville, Seville, Spain.; Sánchez-León ML; Clinical Oncology Service, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain.; Silva-Romeiro S; Clinical Oncology Service, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain.; Flores-Campos R; Clinical Oncology Service, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain.; Carnicero-González F; Department of Hematology, Hospital San Pedro de Alcántara de Cáceres, Cáceres, Spain.; Ríos-Herranz E; Department of Hematology, Hospital Universitario de Valme, Seville, Spain.; de la Cruz-Vicente F; Department of Hematology, Hospital Universitario Virgen del Rocío, Seville, Spain.; Rodríguez-García G; Department of Hematology, Hospital Universitario Virgen del Rocío, Seville, Spain.; Fernández-Álvarez R; Department of Hematology, Cabueñes Hospital, Gijón, Spain.; Martínez-Banaclocha N; Oncology Dept., Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.; Gumà-Padrò J; Department of Clinical Oncology, Hospital Universitari Sant Joan de Reus URV, IISPV, Reus, Spain.; Gómez-Codina J; Department of Clinical Oncology, Hospital Universitario La Fé, Valencia, Spain.; Salar-Silvestre A; Department of Hematology, Hospital del Mar, Barcelona, Spain.; Rodríguez-Abreu D; Department of Clinical Oncology, Hospital Universitario Insular, Las Palmas de Gran Canaria, Spain.; Gálvez-Carvajal L; Department of Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain.; Labrador J; Department of Hematology, Research Unit, Hospital Universitario de Burgos, Burgos, Spain.; Guirado-Risueño M; Department of Clinical Oncology, Hospital General Universitario de Elche, Elche, Spain.; Provencio-Pulla M; Department of Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, Facultad de Medicina, Universidad Autónoma de Madrid, IDIPHISA, Madrid, Spain.; Sánchez-Beato M; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, CIBERONC, Madrid, Spain.; Marylene L; Department of Pathology, Plataforma de Estudios Histológicos, Citológicos y de Digitalización, Hospital de Tortosa Verge de la Cinta, IISPV, URV, Tortosa, Tarragona, Spain.; Álvaro-Naranjo T; Department of Pathology, Hospital de Tortosa Verge de la Cinta, Catalan Institute of Health, Institut d'Investigació Sanitària Pere Virgili (IISPV), Tortosa, Tarragona, Spain.; Casanova-Espinosa M; Department of Hematology/Clinical Oncology, Hospital Costa del Sol, Marbella, Spain.; Rueda-Domínguez A; Department of Hematology/Clinical Oncology, Hospital Costa del Sol, Marbella, Spain.; Sánchez-Margalet V; Clinical Biochemistry Service, Virgen Macarena University Hospital, University of Seville, Seville, Spain.; Department of Medical Biochemistry and Molecular Biology and Immunology, Medical School, Virgen Macarena University Hospital, University of Seville, Seville, Spain.; Institute of Biomedicine of Seville, Virgen Macarena University Hospital, CSIC, University of Seville, Seville, Spain.; de la Cruz-Merino L; Institute of Biomedicine of Seville, Virgen Macarena University Hospital, CSIC, University of Seville, Seville, Spain.; Clinical Oncology Service, Hospital Universitario Virgen Macarena, University of Seville, Seville, Spain.; Department of Medicine, University of Seville, Seville, Spain.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Academic Journal
Godoy-Ortíz A; Department of Medical Oncology, Virgen de La Victoria University Hospital, Malaga, Spain.; The Biomedical Research Institute of Malaga (IBIMA-CIMES-UMA), Malaga, Spain.; Centro de Investigacion Biomedica en Red de Cáncer (CIBERONC-CB16/12/00481), Madrid, Spain.; Lendínez-Sánchez G; The Biomedical Research Institute of Malaga (IBIMA-CIMES-UMA), Malaga, Spain.; Department of Medical Oncology, Hospital Regional Universitario de Malaga, Malaga, Spain.; Zalabardo M; Department of Medical Oncology, Virgen de La Victoria University Hospital, Malaga, Spain.; The Biomedical Research Institute of Malaga (IBIMA-CIMES-UMA), Malaga, Spain.; Pascual J; Department of Medical Oncology, Virgen de La Victoria University Hospital, Malaga, Spain.; The Biomedical Research Institute of Malaga (IBIMA-CIMES-UMA), Malaga, Spain.; Centro de Investigacion Biomedica en Red de Cáncer (CIBERONC-CB16/12/00481), Madrid, Spain.; López-Pascual A; The Biomedical Research Institute of Malaga (IBIMA-CIMES-UMA), Malaga, Spain.; Department of Medical Oncology, Hospital Regional Universitario de Malaga, Malaga, Spain.; Cantero A; The Biomedical Research Institute of Malaga (IBIMA-CIMES-UMA), Malaga, Spain.; Department of Medical Oncology, Hospital Regional Universitario de Malaga, Malaga, Spain.; Ribelles N; Department of Medical Oncology, Virgen de La Victoria University Hospital, Malaga, Spain.; The Biomedical Research Institute of Malaga (IBIMA-CIMES-UMA), Malaga, Spain.; Iglesias M; Department of Medical Oncology, Virgen de La Victoria University Hospital, Malaga, Spain.; The Biomedical Research Institute of Malaga (IBIMA-CIMES-UMA), Malaga, Spain.; Villar E; The Biomedical Research Institute of Malaga (IBIMA-CIMES-UMA), Malaga, Spain.; Department of Medical Oncology, Hospital Regional Universitario de Malaga, Malaga, Spain.; Pajares B; Department of Medical Oncology, Virgen de La Victoria University Hospital, Malaga, Spain.; The Biomedical Research Institute of Malaga (IBIMA-CIMES-UMA), Malaga, Spain.; Díaz-Redondo T; The Biomedical Research Institute of Malaga (IBIMA-CIMES-UMA), Malaga, Spain.; Department of Medical Oncology, Hospital Regional Universitario de Malaga, Malaga, Spain.; Domínguez-Recio ME; Department of Medical Oncology, Virgen de La Victoria University Hospital, Malaga, Spain.; The Biomedical Research Institute of Malaga (IBIMA-CIMES-UMA), Malaga, Spain.; Carabantes F; The Biomedical Research Institute of Malaga (IBIMA-CIMES-UMA), Malaga, Spain.; Department of Medical Oncology, Hospital Regional Universitario de Malaga, Malaga, Spain.; Bermejo MJ; Department of Medical Oncology, Virgen de La Victoria University Hospital, Malaga, Spain.; The Biomedical Research Institute of Malaga (IBIMA-CIMES-UMA), Malaga, Spain.; Rueda-Domínguez A; Department of Medical Oncology, Virgen de La Victoria University Hospital, Malaga, Spain.; The Biomedical Research Institute of Malaga (IBIMA-CIMES-UMA), Malaga, Spain.; Alba E; Department of Medical Oncology, Virgen de La Victoria University Hospital, Malaga, Spain.; The Biomedical Research Institute of Malaga (IBIMA-CIMES-UMA), Malaga, Spain.; Centro de Investigacion Biomedica en Red de Cáncer (CIBERONC-CB16/12/00481), Madrid, Spain.; Faculty of Medicine, University of Malaga, Malaga, Spain.; Sánchez-Muñoz A; Department of Medical Oncology, Virgen de La Victoria University Hospital, Malaga, Spain.; The Biomedical Research Institute of Malaga (IBIMA-CIMES-UMA), Malaga, Spain.; Faculty of Medicine, University of Malaga, Malaga, Spain.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Academic Journal
Jean-Pascal MachielsYungan TaoLisa LicitraBarbara BurtnessMakoto TaharaDanny RischinGustavo AlvesIane Pinto Figueiredo LimaBrett G M HughesYoann PointreauSercan AksoySimon LabanRichard GreilMartin BurianMarcin HetnałJean-Pierre DelordRicard MesíaMiren TabernaJohn N WaldronChristian SimonVincent GrégoireKevin J HarringtonRamona F SwabyYayan ZhangBurak GumuscuBehzad BidadiLillian L SiuBrett GM HughesBo GaoMargaret McGrathDietmar ThurnherThorsten FuerederSylvie RotteyPaul M ClementStéphanie HenryStéphanie DeheneffeGustavo Vasconcelos AlvesJosiane Mourão DiasPedro Rafael Martins De MarchiMilena Perez MakAndrea Juliana Pereira de Santana GomesDalvaro Oliveira de Castro JuniorTatiane Cardoso MottaMonica Luciana Agostinho PadoanAna Paula VictorinaSergio Jobim de AzevedoStephanie BruleJohn HiltonChang Shu WangNathaniel BouganimMarc WebsterJohn WalkerNeil ChuaAngela Regina ZambranoAlicia Quiroga EcheverriOscar Mauricio Niño GomezCarlos Alberto OrtizLuis RojasAndrés Cardona ZorillaOlga Marcela Urrego MeléndezPetra Beran HolečkováBohuslav MelicharJakub CvekJana PrausováMilan VošmikXavier ZasadnyLionnel GeoffroisRainer FietkauMarlen HaderleinAndreas H MuellerUrsula SchroederBarbara WollenbergPhilipp IvanyiViktor GruenwaldPhilippe SchafhausenOrit GutfeldIris GluckAron PopovtzerAmichay MeirovitzSalem BillanBaruch BrennerDror LimonFrancesco PerriFrancesco CaponigroMartina ViolatiDaris FerrariFranco NoleFederica BertoliniLorenzo LiviMaria Grazia GhiIlaria ImarisioAkihiro HommaTsutomu UedaYukinori AsadaTomoko YamazakiKoji MatsumotoTakashi FujiiSadakatsu IkedaShunji TakahashiTakashi KinoshitaKeita SasakiAkihito TsujiMyung-Ju AhnByoung Chul ChoKeun-Wook LeeKi Hyeong LeeMoon Ki ChoiHwan Jung YunMathijs P HendriksSjoukje F OostingJan ButerEsther Van MeertenJonathan GrahamAndrzej KaweckiIzabella DebickaAdam MaciejczykMaciej PyszDorota FilarskaPiotr KoralewskiAndrzej WygodaKrzysztof SkładowskiMałgorzata TalerczykAlfonso Berrocal JaimePedro Pérez SeguraIrene Braña GarcíaNeus Basté RotllanRicard Mesía NinMiren Taberna SanzLara Iglesias DocampoAinara Soria RivasAntonio Rueda DomínguezJosé Manuel Trigo PérezRuey-Long HongShau-Hsuan LiHung-Ming WangChia-Jui YenMuh-Hwa YangYi-Fang ChangYi-Chun LiuJin-Ching LinMeltem EkenelHakan HarputluoğluÖzgür ÖzyilkanAhmet BılıcıMehmet Alı Nahıt ŞendurCagatay ArslanKevin HarringtonShanmugasundaram RamkumarDorothy GujralSimon StewartMelanie PowellAmen SibtainTom RoquesKent YipArafat MirzaMuthiah SivaramalingamNeil D BelmanSanjiv AgarwalaIan AndersonArpan PatelRonald MaggioreMegan BaumgartMary Jo FidlerVarinder KaurElizabeth GaughanFrancis WordenCristina P RodriguezAmmar SukariDeborah WongSue YomWilliam V WalshJoseph A FiorilloJeffrey T YorioGrzegorz S Obara
KEYNOTE-412 Investigators 2024, 'Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412) : a randomised, double-blind, phase 3 trial', The Lancet Oncology, vol. 25, no. 5, pp. 572-587. https://doi.org/10.1016/S1470-2045(24)00100-1
Academic Journal
Velasco-Suelto J; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de La Victoria, 29010, Malaga, Spain.; The Biomedical Research Institute of Málaga, IBIMA-CIMES-UMA), 29010, Malaga, Spain.; Gálvez-Carvajal L; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de La Victoria, 29010, Malaga, Spain.; The Biomedical Research Institute of Málaga, IBIMA-CIMES-UMA), 29010, Malaga, Spain.; Comino-Méndez I; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de La Victoria, 29010, Malaga, Spain. inaki.comino@ibima.eu.; The Biomedical Research Institute of Málaga, IBIMA-CIMES-UMA), 29010, Malaga, Spain. inaki.comino@ibima.eu.; Andalusia-Roche Network in Precision Medical Oncology, 41092, Seville, Spain. inaki.comino@ibima.eu.; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC - CB16, 12/00481); 28029, Madrid, Spain. inaki.comino@ibima.eu.; Clinical and Translational Cancer Research Group, IBIMA Institute, C/ Severo Ochoa, ParqueTecnologico de Andalucia (PTA), 35, 29590, Campanillas-Malaga, Spain. inaki.comino@ibima.eu.; Rueda-Domínguez A; Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de La Victoria, 29010, Malaga, Spain.; The Biomedical Research Institute of Málaga, IBIMA-CIMES-UMA), 29010, Malaga, Spain.; Andalusia-Roche Network in Precision Medical Oncology, 41092, Seville, Spain.
Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE
Academic Journal
Pérez-Ruiz E; Unidad de Gestión Clínica Intercentros de Oncología Médica, Oncology Department, Institute of Biomedical Investigation of Malaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, 29010 Malaga, Spain.; Gutiérrez V; Unidad de Gestión Clínica Intercentros de Oncología Médica, Oncology Department, Institute of Biomedical Investigation of Malaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, 29010 Malaga, Spain.; Muñoz M; Unidad de Gestión Clínica Intercentros de Oncología Médica, Oncology Department, Institute of Biomedical Investigation of Malaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, 29010 Malaga, Spain.; Oliver J; Researcher Unit, Unidad de Gestión Clínica Intercentros de Oncología Médica, Institute of Biomedical Investigation of Malaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, 29010 Malaga, Spain.; Sánchez M; Maxillofacial Surgery Department, Hospital Regional Universitario de Málaga, 29010 Málaga, Spain.; Gálvez-Carvajal L; Unidad de Gestión Clínica Intercentros de Oncología Médica, Oncology Department, Institute of Biomedical Investigation of Malaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, 29010 Malaga, Spain.; Rueda-Domínguez A; Unidad de Gestión Clínica Intercentros de Oncología Médica, Oncology Department, Institute of Biomedical Investigation of Malaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, 29010 Malaga, Spain.; Barragán I; Researcher Unit, Unidad de Gestión Clínica Intercentros de Oncología Médica, Institute of Biomedical Investigation of Malaga (IBIMA), Hospitales Universitarios Regional y Virgen de la Victoria, 29010 Malaga, Spain.; Group of Pharmacoepigenetics, Department of Physiology and Pharmacology, Karolinska Institutet, 171 77 Stockholm, Sweden.
Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE
Academic Journal
Clin Transl Oncol
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
CLINICAL & TRANSLATIONAL ONCOLOGY
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Instituto de Investigación Sanitaria La Fe (IIS La Fe)
Academic Journal
Gutiérrez Calderón V; Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga, Spain.; Cantero González A; Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga, Spain.; Gálvez Carvajal L; Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga, Spain.; Aguilar Lizarralde Y; Servicio de Cirugía Maxilofacial, Hospital Regional Universitario, Málaga, Spain.; Rueda Domínguez A; Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Carlos Haya Avenue, s/n, Málaga, Spain.
Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Rueda-Domínguez, A.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어